Adecuar el rótulo al diagnóstico | 12 AGO 18

Alergia a los antibióticos en pediatría

El rótulo de alergia a antibióticos conduce a importantes consecuencias en la salud individual y pública.
1
5
Autor/a: Allison Eaddy Norton, Katherine Konvinse, Elizabeth J. Phillips y colaboradores Pediatrics. 2018; 141(5)
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Vyles D, Chiu A, Simpson P, Nimmer M, Adams J, Brousseau DC. Parentreported penicillin allergy symptoms in the pediatric emergency department. Acad Pediatr. 2017;17(3):251–255

2. Chiriac AM; Demoly P. . . Drug Allergy. In: Leung DY, Sampson HA, Bonilla FA, Akdis CA, Szefler SJ, eds. Pediatric Allergy: Principles and Practice, 3rd ed. . . . Edinburgh: Elsevier; 2016:498–504

3. MacFadden DR, LaDelfa A, Leen J, et al. Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study. Clin Infect Dis. 2016;63(7):904–910

4. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol. 2014;133(3):790–796

5. Vyles D, Adams J, Chiu A, Simpson P, Nimmer M, Brousseau DC. Allergy testing in children with low-risk penicillin allergy symptoms. Pediatrics.2017;140(2):e20170471

6. Rebelo Gomes E, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting toconfirmed diagnosis. Clin Exp Allergy.2008;38(1):191–198

7. Vezir E, Erkocoglu M, Civelek E, et al. The evaluation of drug provocationtests in pediatric allergy clinic: a single center experience. Allergy Asthma Proc. 2014;35(2):156–162

8. Picard M, Paradis L, Nguyen M, Bégin P, Paradis J, Des Roches A. Outpatient penicillin use after negative skin testing and drug challenge in a pediatric population. Allergy Asthma

Proc. 2012;33(2):160–164

9. Gerace KS, Phillips E. Penicillin allergy label persists despite negative testing. J Allergy Clin Immunol Pract. 2015;3(5):815–816

10. MacLaughlin EJ, Saseen JJ, Malone DC. Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported betalactam allergy. Arch Fam Med. 2000;9(8):722–726

11. Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiology,and antibiotic treatment of acute otitis media in children: a systematic review. JAMA. 2010;304(19):2161–2169

12. Phillips E, Mallal S. Drug hypersensitivity in HIV. Curr Opin Allergy Clin Immunol. 2007;7(4):324–330

13. Caimmi S, Sanfiorenzo C, Caimmi D, Bousquet PJ, Chiron R, Demoly P. Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics. Clin Transl Allergy. 2012;2(1):10

14. Petroni DH, Aitken ML, Ham E, et al.Approach to the evaluation of adverseantibiotic reactions in patients with cystic fibrosis. Ann Allergy Asthma Immunol. 2016;117(4):378–381

15. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. 2005;115(4):1048–1057

16. Cohen AL, Budnitz DS, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr. 2008;152(3):416–421

17. Star K, Norén GN, Nordin K, Edwards IR. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf. 2011;34(5):415–428

18. Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics. 2006;118(2):555–562

19. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005;5(4):309–316

20. Chan DS, Callahan CW, Moreno C. Multidisciplinary education and management program for children with asthma. Am J Health Syst Pharm. 2001;58(15):1413–1417

21. Kerr JR. Penicillin allergy: a study of incidence as reported by patients. Br J Clin Pract. 1994;48(1):5–7

22. Smyth RM, Gargon E, Kirkham J, et al. Adverse drug reactions in children—a systematic review. PLoS One. 2012;7(3):e24061

23. Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA. 1993;270(20):2456–2463

24. Macy E, Poon K-Y T. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med. 2009;122(8):778.e1–778.e7

25. Vezir E, Erkocoglu M, Civelek E, et al. The evaluation of drug provocationtests in pediatric allergy clinic: a single center experience. Allergy Asthma Proc. 2014;35(2):156–162

26. Ponvert C, Perrin Y, Bados-Albiero A, et al. Allergy to beta-lactam antibioticsin children: results of a 20-yearstudy based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22(4):411–418

27. Iglesias-Souto J, González R, Poza P, Sanchez-Machín I, Matheu V. Evaluating the usefulness of retesting for betalactam allergy in children. Pediatr Infect Dis J. 2012;31(10):1091–1093

28. Mattheij M, de Vries E. A suspicion of antibiotic allergy in children is often incorrect. J Allergy Clin Immunol. 2012;129(2):583; author reply 583–584

29. Seitz CS, Bröcker EB, Trautmann A. Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing. Pediatr Allergy Immunol. 2011;22(4):405–410

30. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med. 2004;140(12):1001–1006

31. Caubet JC, Kaiser L, Lemaître B, FellayB, Gervaix A, Eigenmann PA. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol. 2011;127(1):218–222

32. Caubet JC, Eigenmann PA. Managing possible antibiotic allergy in children. Curr Opin Infect Dis.2012;25(3):279–285

33. Erkoçoglu M, Kaya A, Civelek E, et al. Prevalence of confirmed immediatetype drug hypersensitivity reactions among school children. Pediatr Allergy Immunol. 2013;24(2):160–167

34. Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy is not necessarily forever. JAMA. 2017;318(1):82–83

35. Atanaskovic-Markovic M, Gaeta F, Medjo B, et al. Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children - our 10-year experience in allergy work-up. Pediatr Allergy Immunol. 2016;27(5):533–538

36. Arikoglu T, Aslan G, Batmaz SB, Eskandari G, Helvaci I, Kuyucu S. Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests. Int J Clin Pharm. 2015;37(4):583–591

37. Chambel M, Martins P, Silva I, PalmaCarlos S, Romeira AM, Leiria Pinto P. Drug provocation tests to betalactam antibiotics: experience in a paediatric setting. Allergol Immunopathol (Madr). 2010;38(6):300–306

38. Romano A, Caubet J-C. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract. 2014;2(1):3–12

39. Ibia EO, Schwartz RH, Wiedermann BL. Antibiotic rashes in children: a survey in a private practice setting. Arch Dermatol. 2000;136(7):849–854

40. Solensky R. Allergy to β-lactam antibiotics. J Allergy Clin Immunol. 2012;130(6):1442–1442.e5

41. Pawankar R, Canonica GW, Holgate ST, Lockey RF. WAO White Book on Allergy 2011-2012 Executive Summary. Milwaukee, WI: World Allergy Association; 2011

42. Torres MJ, Ariza A, Mayorga C, et al. Clavulanic acid can be thecomponent in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol. 2010;125(2):502–505.e2

43. Zambonino MA, Corzo JL, Muñoz C, et al. Diagnostic evaluation ofhypersensitivity reactions to betalactamantibiotics in a large population of children. Pediatr Allergy Immunol. 2014;25(1):80–87

44. Gomes ER, Brockow K, Kuyucu S, et al; ENDA/EAACI Drug Allergy Interest Group. Drug hypersensitivity in children: report from the pediatric task force of the EAACIDrug Allergy Interest Group. Allergy. 2016;71(2):149–161

45. Barni S, Butti D, Mori F, et al. Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides. J Investig Allergol Clin Immunol. 2015;25(2):128–132

46. Mori F, Pecorari L, Pantano S, et al. Azithromycin anaphylaxis in children. Int J Immunopathol Pharmacol.2014;27(1):121–126

47. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma, and Immunology; Joint Council of Allergy, Asthma, and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259–273

48. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7): 588–597

49. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl JMed. 1994;331(19):1272–1285

50. Gómez-Traseira C, Boyano-Martínez T, Escosa-García L, Pedrosa M, Martín Muñoz F, Quirce S. Trimethoprim sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl. Pediatr Allergy Immunol.2015;26(3):287–289

51. Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71(5):684–700

52. Garon SL, Pavlos RK, White KD, Brown NJ, Stone CA Jr, Phillips EJ. Pharmacogenomics of off-target adverse drug reactions. Br J Clin Pharmacol. 2017;83(9):1896–1911

53. White KD, Chung WH, Hung SI, Mallal S, Phillips EJ. Evolving models of the immunopathogenesis of T cellmediated drug allergy: the role of host, pathogens, and drug response. J Allergy Clin Immunol. 2015;136(2):219–234; quiz 235

54. Phillips EJ. Classifying ADRs—does dose matter? Br J Clin Pharmacol. 2016;81(1):10–12

55. Dioun AF. Management of multipledrug allergies in children. Curr AllergyAsthma Rep. 2012;12(1):79–84

56. Caubet JC, Eigenmann PA. Diagnostic issues in pediatric drug allergy. Curr Opin Allergy Clin Immunol. 2012;12(4):341–347

57. McNeil BD, Pundir P, Meeker S, et al. Identification of a mast-cell specific receptor crucial for pseudoallergic drug reactions. Nature. 2015;519(7542):237–241

58. Azimi E, Reddy VB, Lerner EA. Brief communication: MRGPRX2, atopic dermatitis and red man syndrome. Itch (Phila). 2017;2(1):e5

59. Gell P, Coombs R, Lachmann P. Classification of allergic reactions for clinical hypersensitivity disease. In: Gell PGH, Coombs RPA, eds. Clinical Aspects of Immunology. Oxford, United Kingdom: Blackwell Scientific Publications; 1968:575–579

60. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139(8):683–693

61. Pichler WJ, Beeler A, Keller M, et al. Pharmacological interaction of drugs with immune receptors: the p-I concept. Allergol Int. 2006;55(1):17–25

62. Aung AK, Haas DW, Hulgan T, Phillips EJ. Pharmacogenomics of antimicrobial agents. Pharmacogenomics. 2014;15(15):1903–1930

63. Trubiano J, Phillips E. Antimicrobial stewardship’s new weapon? A review of antibiotic allergy and pathways to ‘de-labeling’. Curr Opin Infect Dis.2013;26(6):526–537

64. Muraro A, Lemanske RF Jr, Castells M, et al. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy.2017;72(7):1006–1021

65. Blanca-Lopez N, Perez-Alzate D, Ruano F, et al. Selective immediate responders toamoxicillin and clavulanic acid toleratepenicillin derivative administration after confirming the diagnosis. Allergy. 2015;70(8):1013–1019

66. Esposito S, Castellazzi L, Tagliabue C, Principi N. Allergy to antibiotics in children: an overestimated problem. Int J Antimicrob Agents. 2016;48(4):361–366

67. Blanca-López N, Ariza A, Doña I, et al. Hypersensitivity reactions tofluoroquinolones: analysis of thefactors involved. Clin Exp Allergy. 2013;43(5):560–567

68. Venturini Díaz M, Lobera Labairu T, del Pozo Gil MD, Blasco Sarramián A, González Mahave I. In vivo diagnostic tests in adverse reactions to quinolones. J Investig Allergol ClinImmunol. 2007;17(6):393–398

69. Pichichero ME, Zagursky R. Penicillin and cephalosporin allergy. AnnAllergy Asthma Immunol. 2014;112(5):404–412

70. Romano A, Gaeta F, Valluzzi RL, et al. IgE-mediated hypersensitivityto cephalosporins: cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol.2015;136(3):685–691.e3

71. Romano A, Gaeta F, Arribas Poves MF, Valluzzi RL. Cross-reactivity amongbeta-lactams. Curr Allergy Asthma Rep.2016;16(3):24

72. Audicana M, Bernaola G, Urrutia I, et al. Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross reactivity with cephalosporin. Allergy. 1994;49(2):108–113

73. Novalbos A, Sastre J, Cuesta J, et al. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy.2001;31(3):438–443

74. Antunez C, Blanca-Lopez N, Torres MJ, et al. Immediate allergic reactions tocephalosporins: evaluation of crossreactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol. 2006;117(2):404–410

75. Romano A, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Bousquet PJ. IgE-mediatedhypersensitivity to cephalosporins:cross-reactivity and tolerabilityof penicillins, monobactams, and

carbapenems. J Allergy Clin Immunol. 2010;126(5):994–999

76. Mill C, Primeau MN, Medoff E, et al. Assessing the diagnostic properties ofa graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr. 2016;170(6):e160033

77. Kuhlen JL Jr, Camargo CA Jr, Balekian DS, et al. Antibiotics are the most commonlyidentified cause of perioperativehypersensitivity reactions. J Allergy Clin Immunol Pract. 2016;4(4):697–704

78. Gonzalez-Estrada A, Silvers SK, Klein A, Zell K, Wang XF, Lang DM.Epidemiology of anaphylaxis at atertiary care center: a report of 730 cases. Ann Allergy Asthma Immunol. 2017;118(1):80–85

79. Gonzalez-Estrada A, Pien LC, Zell K, Wang XF, Lang DM. Antibiotics arean important identifiable cause ofperioperative anaphylaxis in the United States. J Allergy Clin Immunol Pract. 2015;3(1):101–105.e1

80. Hierro Santurino B, Mateos Conde J, Cabero Morán MT, Mirón Canelo JA, Armentia Medina A. A predictive model for the diagnosis of allergic drug reactions according to the medical history. J Allergy Clin Immunol Pract. 2016;4(2):292–300.e3

81. Atanaskovic-Markovic M, Gaeta F, Gavrovic-Jankulovic M, Velickovic TC, Valluzzi RL, Romano A. Tolerability of imipenem in children with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol. 2009;124(1):167–169

82. Romano A, Gaeta F, Valluzzi RL, et al.Absence of cross-reactivity to carbapenems in patients with delayed hypersensitivity to penicillins. Allergy.2013;68(12):1618–1621

83. Romano A, Gaeta F, Valluzzi RL, Maggioletti M, Caruso C, Quaratino D. Cross-reactivity and tolerability of aztreonam and cephalosporins in subjects with a T cell-mediated hypersensitivity to penicillins. J Allergy Clin Immunol. 2016;138(1):179–186

84. Atanaskovic-Markovic M, Gaeta F, Medjo B, Viola M, Nestorovic B, Romano A. Tolerability of meropenemin children with IgE-mediatedhypersensitivity to penicillins. Allergy. 2008;63(2):237–240

85. Romano A, Torres MJ, Castells M, Sanz ML, Blanca M. Diagnosis andmanagement of drug hypersensitivityreactions. J Allergy Clin Immunol. 2011;127(suppl 3):S67–S73

86. Rubio M, Bousquet PJ, Gomes E, Romano A, Demoly P. Results of drug hypersensitivity evaluations in a large group of children and adults. Clin Exp Allergy. 2012;42(1):123–130

87. Segal AR, Doherty KM, Leggott J, Zlotoff B. Cutaneous reactions to drugs in children. Pediatrics. 2007;120(4). Available at: www.pediatrics.org/cgi/content/full/120/4/e1082

88. Peter JG, Lehloenya R, Dlamini S, et al. Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice. J Allergy Clin Immunol Pract. 2017;5(3):547–563

89. Demoly P, Adkinson NF, Brockow K, et al. International consensus on drug allergy. Allergy. 2014;69(4):420–437

90. Cohen AD, Friger M, Sarov B, Halevy S. Which intercurrent infections are associated with maculopapular cutaneous drug reactions? A casecontrol study. Int J Dermatol. 2001;40(1):41–44

91. Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med. 2003;349(17):1628–1635

92. Bass JW, Crowley DM, Steele RW, Young FS, Harden LB. Adverse effects of orally administered ampicillin. J Pediatr. 1973;83(1):106–108

93. Kuyucu S, Mori F, Atanaskovic-Markovic M, et al; Pediatric Task Force of EAACI Drug Allergy Interest Group. Hypersensitivity reactions to nonbetalactam antibiotics in children: an extensive review. Pediatr Allergy Immunol. 2014;25(6):534–543

94. Mayorga C, Celik G, Rouzaire P, et al; In Vitro Tests for Drug Allergy Task Force of EAACI Drug Interest Group. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy.2016;71(8):1103–1134

95. Romano A, Blanca M, Torres MJ, et al; ENDA; EAACI. Diagnosisof nonimmediate reactions to

β-lactam antibiotics. Allergy. 2004;59(11):1153–1160

96. Torres MJ, Blanca M, Fernandez J, et al; ENDA; EAACI Interest Group on DrugHypersensitivity. Diagnosis of immediateallergic reactions to beta-lactamantibiotics. Allergy. 2003;58(10):961–972

97. Greenberger PA. Chapter 30: drug allergy. Allergy Asthma Proc. 2012;33(suppl 1):S103–S107

98. Mirakian R, Ewan PW, Durham SR, et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009;39(1):43–61

99. Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity. Allergy. 1999;54(9):999–1003

100. Atanaskovic-Markovic M, Caubet JC. Management of drug hypersensitivity in the pediatric population [published online ahead of print July 28, 2016]. Expert Rev Clin Pharmacol.

101. Fernandez TD, Mayorga C, Ariza A, Corzo JL, Torres MJ. Allergicreactions to antibiotics in children. Curr Opin Allergy Clin Immunol. 2014;14(4):278–285

102. Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr. 1998;132(1):137–143

103. Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol. 2010;125(2, suppl 2):S126–S137

104. Atanaskovic-Markovic M, Velickovic TC, Gavrovic-Jankulovic M, Vuckovic O, Nestorovic B. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children. Pediatr Allergy Immunol. 2005;16(4):341–347

105. Ponvert C, Le Clainche L, de Blic J, Le Bourgeois M, Scheinmann P, PaupeJ. Allergy to beta-lactam antibiotics in children. Pediatrics. 1999;104(4). Available at: www.pediatrics.org/cgi/content/full/104/4/e45

106. Blanca M, Romano A, Torres MJ, et al. Update on the evaluationof hypersensitivity reactions to betalactams. Allergy. 2009;64(2):183–193

107. Brockow K, Garvey LH, Aberer W, et al; ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702–712

108. Empedrad R, Darter AL, Earl HS, Gruchalla RS. Nonirritatingintradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol. 2003;112(3):629–630

109. Cantani A. Diagnosis of pediatric allergy. In: Cantani A, ed. Pediatric Allergy, Asthma and Immunology. 1sted. Berlin, Germany: Springer-Verlag Berlin Heidelberg; 2008:421–440

110. Ponvert C, Weilenmann C, Wassenberg J, et al. Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests. Allergy. 2007;62(1):42–46

111. Dong SW, Mertes PM, Petitpain N, Hasdenteufel F, Malinovsky JM; GERAP. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol. 2012;78(8):868–878

112. Haw WY, Polak ME, McGuire C, ErlewynLajeunesse M, Ardern-Jones MR. In vitro rapid diagnostic tests for severe drug hypersensitivity reactions in children. Ann Allergy Asthma Immunol. 2016;117(1):61–66

113. Johansson SG, Adédoyin J, van Hage M, Grönneberg R, Nopp A. False-positive penicillin immunoassay: an unnoticed common problem. J Allergy Clin Immunol. 2013;132(1):235–237

114. Hjortlund J, Mortz CG, Stage TB, Skov PS, Dahl R, Bindslev-Jensen C. Positive serum specific IgE has a short halflife in patients with penicillin allergy and reversal does not always indicate tolerance. Clin Transl Allergy. 2014; 4:34

115. Opstrup MS, Poulsen LK, Malling HJ, Jensen BM, Garvey LH. Dynamics of plasma levels of specific IgE inchlorhexidine allergic patients withand without accidental re-exposure.Clin Exp Allergy. 2016;46(8):1090–1098

116. Poulsen LK, Hummelshoj L. Triggers of IgE class switching and allergy development. Ann Med. 2007;39(6):440–456

117. Aranda A, Mayorga C, Ariza A, et al. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy. 2011;66(2):247–254

118. Gamboa PM, García-Avilés MC, Urrutia I, Antépara I, Esparza R, Sanz ML. Basophil activation andsulfidoleukotriene production inpatients with immediate allergy tobetalactam antibiotics and negative skin tests. J Investig Allergol Clin Immunol. 2004;14(4):278–283

119. Hausmann OV, Gentinetta T, Bridts CH, Ebo DG. The basophil activation test in immediate-type drug allergy. Immunol Allergy Clin North Am. 2009;29(3):555–566

120. Torres MJ, Padial A, Mayorga C, et al. The diagnostic interpretation ofbasophil activation test in immediateallergic reactions to betalactams. Clin Exp Allergy. 2004;34(11):1768–1775

121. Porebski G, Pecaric-Petkovic T, GrouxKeller M, Bosak M, Kawabata TT, Pichler WJ. In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test. Clin Exp Allergy. 2013;43(9):1027–1037

122. Rive CM, Bourke J, Phillips EJ. Testing for drug hypersensitivity syndromes. Clin Biochem Rev. 2013;34(1):15–38

123. Trautmann A, Seitz CS, Stoevesandt J, Kerstan A. Aminopenicillin-associated exanthem: lymphocyte transformation testing revisited. Clin Exp Allergy. 2014;44(12):1531–1538

124. Bensaid B, Rozieres A, Nosbaum A, Nicolas JF, Berard F. Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug. J Allergy Clin Immunol. 2012;130(6):1413–1414

125. El-Ghaiesh S, Monshi MM, Whitaker P, et al. Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis. J Pharmacol Exp Ther. 2012;341(3):597–610

126. Jenkins RE, Yaseen FS, Monshi MM, et al. β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis. Chem Res Toxicol. 2013;26(6):963–975

127. Khalil G, El-Sabban M, Al-Ghadban S, et al. Cytokine expression profile of sensitized human T lymphocytes following in vitro stimulation with amoxicillin. Eur Cytokine Netw. 2008;19(3):131–141

128. Phatharacharukul P, Klaewsongkram J. A case of sulfasalazine-induced hypersensitivity syndrome confirmed by enzyme-linked immunospot assay. Allergy Asthma Immunol Res. 2013;5(6):415–417

129. Rozieres A, Hennino A, Rodet K, et al. Detection and quantification of drugspecific T cells in penicillin allergy. Allergy. 2009;64(4):534–542

130. Tanvarasethee B, Buranapraditkun S, Klaewsongkram J. The potential of using enzyme-linked immunospotto diagnose cephalosporin-induced maculopapular exanthems. Acta Derm Venereol. 2013;93(1):66–69

131. Tassignon J, Burny W, Dahmani S, et al. Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, flow cytometry and realtime PCR. J Immunol Methods. 2005;305(2):188–198

132. Trubiano JA, Redwood A, Strautins K, et al. Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis. J Allergy Clin Immunol Pract. 2017;5(3):823–826

133. Khumra S, Chan J, Urbancic K, et al. Antibiotic allergy labels in a liver transplant recipient study. Antimicrob Agents Chemother. 2017;61(5):e00078–e00117

134. Trubiano JA, Leung VK, Chu MY, WorthLJ, Slavin MA, Thursky KA. The impactof antimicrobial allergy labels on antimicrobial usage in cancer patients. Antimicrob Resist Infect Control. 2015;4:23

135. Turvey SE, Cronin B, Arnold AD, Dioun AF. Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Ann Allergy Asthma Immunol. 2004;92(4):426–432

136. Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am. 2009;29(3):585–606

137. Cernadas JR. Desensitization to antibiotics in children. Pediatr Allergy Immunol. 2013;24(1):3–9

138. D’Amelio CM, Del Pozo JL, Vega O, Madamba R, Gastaminza G. Successful desensitization in a child with delayedcotrimoxazole hypersensitivity: a case report. Pediatr Allergy Immunol. 2016;27(3):320–321

139. Petitto J, Chervinskiy SK, Scurlock AM, Perry TT, Jones SM, Pesek RD. Successful clarithromycin desensitization in a macrolidesensitive pediatric patient. J Allergy Clin Immunol Pract. 2013;1(3):307–308

140. Logsdon S, Ramirez-Avila L, Castells M, Dioun A. Successful rifampin desensitization in a pediatric patient with latent tuberculosis. Pediatr Allergy Immunol. 2014;25(4):404–405

141. Berges-Gimeno MP, Stevenson DD. Nonsteroidal anti-inflammatory drug induced reactions and desensitization. J Asthma. 2004;41(4):375–384

142. Demoly P, Messaad D, Sahla H, et al. Six-hour trimethoprim sulfamethoxazole-graded challenge in HIV-infected patients. J Allergy Clin Immunol. 1998;102(6, pt 1):1033–1036

143. Dilley MA, Lee JP, Platt CD, Broyles AD. Rituximab desensitization in pediatric patients: results of a case series. Pediatr Allergy Immunol Pulmonol. 2016;29(2):91–94

144. Brennan PJ, Rodriguez Bouza T, Hsu FI, Sloane DE, Castells MC.Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol. 2009;124(6):1259–1266

145. Scherer K, Brockow K, Aberer W, et al; European Network on Drug Allergy and the EAACI Drug Allergy Interest Group. Desensitization in delayed drug hypersensitivity reactions – an EAACI position paper of the Drug Allergy Interest Group. Allergy. 2013;68(7):844–852

146. Trubiano JA, Thursky KA, Stewardson AJ, et al. Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation. Clin Infect Dis. 2017;65(1):166–174

147. Rimawi RH, Shah KB, Cook PP. Risk of redocumenting penicillin allergy in a cohort of patients with negative penicillin skin tests. J Hosp Med. 2013;8(11):615–618

148. Patel SV, Tarver SA, Alvarez KS, Lutek KE, Schlebus J, Khan DA. Effectiveness of interventions to maintain penicillin allergy label removal as part of an inpatient penicillin allergy testing protocol. J Allergy Clin Immunol. 2017;139(suppl 2):AB183

149. Chen JR, Khan DA. Evaluation of penicillin allergy in the hospitalized patient: opportunities for antimicrobial stewardship. Curr Allergy Asthma Rep. 2017;17(6):40

150. Chen JR, Tarver SA, Alvarez KS, Tran T, Khan DA. A proactive approach to penicillin allergy testing in hospitalized patients. J Allergy Clin Immunol Pract. 2017;5(3):686–693

151. Blumenthal KG, Shenoy ES, Varughese CA, Hurwitz S, Hooper DC, Banerji A. Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy. Ann Allergy Asthma Immunol. 2015;115(4):294–300.e2

152. Blumenthal KG, Shenoy ES, Wolfson AR, et al. Addressing inpatient betalactam allergies: a multihospital implementation. J Allergy Clin Immunol Pract. 2017;5(3):616–625.e7

153. Blumenthal KG, Wickner PG, Hurwitz S, et al. Tackling inpatient penicillin allergies: assessing tools for antimicrobial stewardship. J AllergyClin Immunol. 2017;140(1):154–161.e6

154. Moral L, Garde J, Toral T, FuentesMJ, Marco N. Short protocol for thestudy of paediatric patients with suspected betalactam antibiotic hypersensitivity and low risk criteria. Allergol Immunopathol (Madr). 2011;39(6):337–341

155. Mori F, Cianferoni A, Barni S, Pucci N, Rossi ME, Novembre E. Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions. J Allergy Clin Immunol Pract. 2015;3(3):375–380.e1

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2020